Serious ventricular dysrhythmias after intracoronary papaverine

Robert F. Wilson; Carl W. White

doi:10.1016/0002-9149(88)90281-0

Serious ventricular dysrhythmias after intracoronary papaverine

Robert F. Wilson
, Carl W. White

Medicine - Cardiology Division

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Abstract

Papaverine administered by the intracoronary route is a potent microvascular vasodilator capable of causing a brief 5-fold increase in coronary blood flow velocity in normal coronary arteries.¹ Many investigators have recently used intracoronary papaverine to measure coronary flow reserve in a variety of diseases.^2-4 When we originally reported the use of papaverine, we noted that patients often developed transient lengthening of the QT interval, but that no significant arrhythmias occurred when ≤12 mg of papaverine was administered.⁵ After administering intracoronary papaverine to >300 patients, we observed 2 episodes of serious ventricular dysrhythmias immediately following small doses of intracoronary papaverine.

Original language	English (US)
Pages (from-to)	1301-1302
Number of pages	2
Journal	The American Journal of Cardiology
Volume	62
Issue number	17
DOIs	https://doi.org/10.1016/0002-9149(88)90281-0
State	Published - Dec 1 1988

Bibliographical note

Funding Information:
From the Department of Medicine and the Minnesota Heart and Lung Institute, Univerity of Minnesota, Minneapolis, Minnesota 55455. This study was supported in part by grant ROl HL39185 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. The work was performed during the tenure of a Clinician Scientist Award from the American Heart Association and funds contributed in part by the Minnesota Affiliate. Manuscript received May 5, 1988; revised manuscript received and accepted August 15, 1988.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Publisher link

10.1016/0002-9149(88)90281-0

Find It

Find It at U of M Libraries

Cite this

@article{9b68d5a71d9e492eb1e5c8e3f3859d59,

title = "Serious ventricular dysrhythmias after intracoronary papaverine",

abstract = "Papaverine administered by the intracoronary route is a potent microvascular vasodilator capable of causing a brief 5-fold increase in coronary blood flow velocity in normal coronary arteries.1 Many investigators have recently used intracoronary papaverine to measure coronary flow reserve in a variety of diseases.2-4 When we originally reported the use of papaverine, we noted that patients often developed transient lengthening of the QT interval, but that no significant arrhythmias occurred when ≤12 mg of papaverine was administered.5 After administering intracoronary papaverine to >300 patients, we observed 2 episodes of serious ventricular dysrhythmias immediately following small doses of intracoronary papaverine.",

author = "Wilson, \{Robert F.\} and White, \{Carl W.\}",

note = "Funding Information: From the Department of Medicine and the Minnesota Heart and Lung Institute, Univerity of Minnesota, Minneapolis, Minnesota 55455. This study was supported in part by grant ROl HL39185 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. The work was performed during the tenure of a Clinician Scientist Award from the American Heart Association and funds contributed in part by the Minnesota Affiliate. Manuscript received May 5, 1988; revised manuscript received and accepted August 15, 1988.",

year = "1988",

month = dec,

day = "1",

doi = "10.1016/0002-9149(88)90281-0",

language = "English (US)",

volume = "62",

pages = "1301--1302",

journal = "The American Journal of Cardiology",

issn = "0002-9149",

publisher = "Elsevier Inc.",

number = "17",

}

TY - JOUR

T1 - Serious ventricular dysrhythmias after intracoronary papaverine

AU - Wilson, Robert F.

AU - White, Carl W.

N1 - Funding Information: From the Department of Medicine and the Minnesota Heart and Lung Institute, Univerity of Minnesota, Minneapolis, Minnesota 55455. This study was supported in part by grant ROl HL39185 from the National Heart, Lung, and Blood Institute, Bethesda, Maryland. The work was performed during the tenure of a Clinician Scientist Award from the American Heart Association and funds contributed in part by the Minnesota Affiliate. Manuscript received May 5, 1988; revised manuscript received and accepted August 15, 1988.

PY - 1988/12/1

Y1 - 1988/12/1

N2 - Papaverine administered by the intracoronary route is a potent microvascular vasodilator capable of causing a brief 5-fold increase in coronary blood flow velocity in normal coronary arteries.1 Many investigators have recently used intracoronary papaverine to measure coronary flow reserve in a variety of diseases.2-4 When we originally reported the use of papaverine, we noted that patients often developed transient lengthening of the QT interval, but that no significant arrhythmias occurred when ≤12 mg of papaverine was administered.5 After administering intracoronary papaverine to >300 patients, we observed 2 episodes of serious ventricular dysrhythmias immediately following small doses of intracoronary papaverine.

AB - Papaverine administered by the intracoronary route is a potent microvascular vasodilator capable of causing a brief 5-fold increase in coronary blood flow velocity in normal coronary arteries.1 Many investigators have recently used intracoronary papaverine to measure coronary flow reserve in a variety of diseases.2-4 When we originally reported the use of papaverine, we noted that patients often developed transient lengthening of the QT interval, but that no significant arrhythmias occurred when ≤12 mg of papaverine was administered.5 After administering intracoronary papaverine to >300 patients, we observed 2 episodes of serious ventricular dysrhythmias immediately following small doses of intracoronary papaverine.

UR - https://www.scopus.com/pages/publications/0023781723

UR - https://www.scopus.com/pages/publications/0023781723#tab=citedBy

U2 - 10.1016/0002-9149(88)90281-0

DO - 10.1016/0002-9149(88)90281-0

M3 - Article

C2 - 2461650

AN - SCOPUS:0023781723

SN - 0002-9149

VL - 62

SP - 1301

EP - 1302

JO - The American Journal of Cardiology

JF - The American Journal of Cardiology

IS - 17

ER -

Serious ventricular dysrhythmias after intracoronary papaverine

Abstract

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this